Navigation Links
Alcohol Consumption Questioned

There has been a great deal of controversy over whether drinking alcohol negatively affects bone health in women. A new study reports that moderate // drinking does not increase the risk of osteoporosis.

Researchers in London conducted a study looking at identical twins, alcohol consumption, and bone health. For the study 46 pairs of identical twins were surveyed. In each set of twins, one drank very little while the other drank moderately. Moderate drinking was defined as eight drinks a week. The twins had their bone mineral density measured as well as chemical markers.

While moderate drinking was associated with thinner bones, researchers say there was no clear link between chemical markers in bone turnover and alcohol intake. Therefore, they say alcohol may actually be beneficial to bone health. Researchers also point out that drinking this amount would not likely increase the risk of falls contributing to the fracture rate.

Although the controversy remains about the risk of osteoporosis and alcohol consumption researchers say that their study lends weight to the growing evidence that moderate alcohol consumption is not detrimental to bone health in women.
'"/>




Page: 1

Related medicine news :

1. Alcohol shrinks brain
2. Alcohol linked to brain activity
3. Alcohol within the body
4. Alcoholism Drug Fails To Prevent Drinking Relapses
5. Alcoholics are prone to disability
6. Alcohol decreases risk of dementia
7. Alcohol injures stress hormone response
8. Role of wives of Alcoholics
9. Antiseizure Drug in help for Alcoholics
10. Alcohol is no tonic for sleep
11. Alcohol and Sun Don’t Mi
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Alcohol Consumption Questioned

Breaking Medicine Technology:New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Evolution of the appendix 3A A biological remnant no more 9645 1Evolution of the appendix 3A A biological remnant no more 9645 2Evolution of the appendix 3A A biological remnant no more 9645 3Georgia Reproductive Specialists Free Infertility Seminar 3A Fertility Options 101 54991 1Naren Mallakunta Joins LAXAI 13639 1Naren Mallakunta Joins LAXAI 13639 2